GILD

Gilead Is Set To Grow

moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]

[$$] Gilead Sciences’ Earnings Triple on New Hepatitis Drug

[at The Wall Street Journal] – Gilead Sciences reported nearly $2.3 billion in first-quarter sales for its new hepatitis C treatment Sovaldi in what is believed to be the best-selling prescription drug launch in history. moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to […]

[$$] Gilead Sciences’ Earnings Triple on New Hepatitis Drug

[at The Wall Street Journal] – Gilead Sciences reported nearly $2.3 billion in first-quarter sales for its new hepatitis C treatment Sovaldi in what is believed to be the best-selling prescription drug launch in history. moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to […]